Canada signs MOUs, makes investments for Canada-produced vaccines through NRC, USask

The Government of Canada has made a series of important announcements related to the COVID-19 vaccine. Among the announcements were the signing of an MOU that will see tens of millions of vaccine doses developed at the National Research Council’s Royalmount facility in Montreal and a $46M investment into a vaccine development facility at the University of Saskatchewan. Once the facility is complete, 680 News reports that USask’s VIDO-InterVAC projects that they will be able to produce millions of doses annually. “We need as much domestic capacity for vaccine production as possible,” said Prime Minister Justin Trudeau. "We won't rest until every Canadian who wants a vaccine has received one." CBC | 680 News (National)